Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-004956
Filing Date
2021-01-19
Accepted
2021-01-19 06:41:32
Documents
5
Period of Report
2021-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm213031d1_6k.htm 6-K 14956
2 EXHIBIT 99.1 tm213031d1_ex99-1.htm EX-99.1 419869
3 GRAPHIC tm213031d1_10-ximg010.jpg GRAPHIC 2591
4 GRAPHIC tm213031d1_10-ximg014.jpg GRAPHIC 6387
5 GRAPHIC tm213031d1_10-ximg016.jpg GRAPHIC 7226
  Complete submission text file 0001104659-21-004956.txt   458723
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 21533805
SIC: 2834 Pharmaceutical Preparations